Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202111

Expand all

PEMETREXED DISODIUM (PEMETREXED DISODIUM)
EQ 100MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PEMETREXED DISODIUM
Proprietary Name: PEMETREXED DISODIUM
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 100MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202111
Product Number: 001
Approval Date: May 25, 2022
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PEMETREXED DISODIUM (PEMETREXED DISODIUM)
EQ 500MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PEMETREXED DISODIUM
Proprietary Name: PEMETREXED DISODIUM
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202111
Product Number: 002
Approval Date: May 25, 2022
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PEMETREXED DISODIUM (PEMETREXED DISODIUM)
EQ 1GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PEMETREXED DISODIUM
Proprietary Name: PEMETREXED DISODIUM
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202111
Product Number: 003
Approval Date: May 25, 2022
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information